Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Clinical Laboratory Analysis|April 20, 2022
Chromosomal microarray in postnatal diagnosis of congenital anomalies and neurodevelopmental disorders in Serbian patientsDijana Perovic, Tatjana Damnjanovic, Biljana Jekic, et al.
Journal of Pediatric Hematology/Oncology|May 7, 2010
Association between the methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia in Serbian childrenTatjana Damnjanovic, Radomir Milicevic, Tanja Novkovic, et al.
Archives of Medical Science : AMS|June 14, 2023
Association of PRDM16 rs12409277 and CtBP2 rs1561589 gene polymorphisms with lipid profile of adolescentsNela Maksimovic, Vanja Vidovic, Tatjana Damnjanovic, et al.
Pharmacogenomics|September 17, 2016
Association of 63/91 length polymorphism in the DHFR gene major promoter with toxicity of methotrexate in patients with rheumatoid arthritisBiljana Jekic, Dubravka Vejnovic, Vera Milic, et al.
Cancer Genetics and Cytogenetics|April 25, 2006
Lack of TP53 and FMS gene mutations in children with myelodysplastic syndromeBiljana Jekic, Ivana Novakovic, Ljiljana Lukovic, et al.
Neurological Research|October 19, 2023
Association of IL-6 rs1800795, but not TNF-α rs1800629, and IL-1β rs16944 polymorphisms' genotypes with recovery of ischemic stroke patients following thrombolysisMarija Dusanovic Pjevic, Ljubica Vojvodic, Milka Grk, et al.
Pharmacotherapy|May 4, 2021
TT genotype of the MMP-9-1562C/T polymorphism may be a risk factor for thrombolytic therapy-induced hemorrhagic complications after acute ischemic strokeMarija Dusanovic Pjevic, Biljana Jekic, Ljiljana Beslac Bumbasirevic, et al.
Clinical and Experimental Rheumatology|February 14, 2012
Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritisVera Milic, Biljana Jekic, Ljiljana Lukovic, et al.
The Turkish Journal of Pediatrics|December 23, 2015
Subtelomeric screening in Serbian children with dysmorphic features and unexplained developmental delay/intellectual disabilitiesTatjana Damnjanovic, Goran Cuturilo, Nela Maksimovic, et al.
European Journal of Clinical Pharmacology|July 6, 2012
Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patientsBiljana Jekic, Ljiljana Lukovic, Vera Bunjevacki, et al.
Pageof 3